Home Markets Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Andrew M Dec 21, 2024 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/lillys-weightloss-drug-zepbound-wins-us-fda-approval-for-sleep-apnea-3785420 FDA first FDA-approved drug Market Updates www.investing.com/news/stock-market-news/lillys-weightloss-drug-zepbound-wins-us-fda-approval-for-sleep-apnea-3785420